BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2282129)

  • 1. The dexamethasone suppression test in dementia: a review of the literature.
    Skare S; Pew B; Dysken M
    J Geriatr Psychiatry Neurol; 1990; 3(3):124-38. PubMed ID: 2282129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the dexamethasone suppression test with depressed and demented elderly.
    Gierl B; Groves L; Lazarus LW
    J Am Geriatr Soc; 1987 Feb; 35(2):115-20. PubMed ID: 3805553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia.
    Raskind M; Peskind E; Rivard MF; Veith R; Barnes R
    Am J Psychiatry; 1982 Nov; 139(11):1468-71. PubMed ID: 7137397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in dementia.
    Magni G; Schifano F; De Leo D; Zangaglia O
    Ital J Neurol Sci; 1987 Apr; 8(2):125-8. PubMed ID: 3597052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression in dementia, depression, and normal aging.
    Georgotas A; McCue RE; Kim OM; Hapworth WE; Reisberg B; Stoll PM; Sinaiko E; Fanelli C; Stokes PE
    Am J Psychiatry; 1986 Apr; 143(4):452-6. PubMed ID: 3953888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test in demented outpatients with and without depression.
    Carnes M; Smith JC; Kalin NH; Bauwens SF
    Psychiatry Res; 1983 Aug; 9(4):337-44. PubMed ID: 6580662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DST studies in psychotic depression: a meta-analysis.
    Nelson JC; Davis JM
    Am J Psychiatry; 1997 Nov; 154(11):1497-503. PubMed ID: 9356556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone suppression test in depression with reversible dementia.
    Alexopoulos GS; Young RC; Haycox JA; Shamoian CA; Blass JP
    Psychiatry Res; 1985 Dec; 16(4):277-85. PubMed ID: 4089057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression test and response to antidepressant therapy in psychogeriatric patients.
    Shrimankar J; Soni SD; Sampath G
    Acta Psychiatr Scand; 1988 Jun; 77(6):712-8. PubMed ID: 3407439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DST as a predictor of outcome in depression: a meta-analysis.
    Ribeiro SC; Tandon R; Grunhaus L; Greden JF
    Am J Psychiatry; 1993 Nov; 150(11):1618-29. PubMed ID: 8214170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
    Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia.
    Rabey JM; Scharf M; Oberman Z; Zohar M; Graff E
    Biol Psychiatry; 1990 Mar; 27(6):581-91. PubMed ID: 2157505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in patients with presenile and senile dementia of the Alzheimer's type.
    Jenike MA; Albert MS
    J Am Geriatr Soc; 1984 Jun; 32(6):441-4. PubMed ID: 6725805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisteroid analysis after DST in depressed patients--a controlled study.
    Holsboer F; Philipp M; Steiger A; Gerken A
    J Affect Disord; 1986; 10(3):241-9. PubMed ID: 2943779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment and cortisol resistance to dexamethasone suppression in elderly depression.
    Siegel B; Gurevich D; Oxenkrug GF
    Biol Psychiatry; 1989 Jan; 25(2):229-34. PubMed ID: 2930804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test with mildly to moderately depressed outpatients.
    Rabkin JG; Quitkin FM; Stewart JW; McGrath PJ; Puig-Antich J
    Am J Psychiatry; 1983 Jul; 140(7):926-7. PubMed ID: 6859319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of dexamethasone suppression test in early Alzheimer dementia.
    De Leo D; Schifano F; Magni G
    Eur Arch Psychiatry Neurol Sci; 1988; 238(1):19-21. PubMed ID: 3215214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.